Meiji Seika Pharma Co. Ltd. is gearing up to strengthen its production capacity for injection-administered antibacterial drugs. Holding the top share of Japan’s antibacterial market, and continuing to operate at...
medical
University of Tsukuba Discovers New Method to Regenerate Heart Muscle With Gene Injection
A research group led by Professor Masaki Ieda of the University of Tsukuba has discovered that the TBX6 gene can directly regenerate cardiovascular tissue when injected into cardiac fibroblasts. Previous...
Mitsui Chemicals Plans European Clinical Research for Sepsis Testing Technology
Mitsui Chemicals Inc. (TYO:4183) is looking to expand R&D efforts overseas with its new testing technology for sepsis, a severe infectious disease. This comes as part of a plan to...
Takagi Seiko Targets Growth With Production of Needle-Free Injector Parts
Takagi Seiko Corp. (TYO:4242) is aiming to leverage its precision molding technologies to expand its business in the medical device field. These efforts have already seen the Toyama Prefecture-based company...
Mitsubishi Chemical Goes on Front Foot in Medical Materials
Mitsubishi Chemical Corp. is embarking on a charge in medical materials. In the area of medical compounds, Mitsubishi Chemical has developed a novel cyclic block copoylmer (CBC). Given that cyclo-olefin...
Eisai Eyes AI for Drug Discovery
Eisai Co. Ltd. (TYO:4523) is increasingly tapping into AI for its drug discovery research. This past June, the company began using an AI system developed in partnership with the University...
Toray Develops Blood-Purifying Fiber Adsorbent With Application in Preventing Respiratory Failure
Toray Industries Inc. (TYO:3402) has developed a fiber adsorbent for purifying blood, able to selectively eliminate activated leukocyte cells and cytokine proteins that lead to respiratory failure. It is a...
Daiichi Sankyo Sees Pillar of Growth in Next-Gen Biopharmaceuticals
Daiichi Sankyo Co. Ltd. (TYO:4568) is making antibody drug conjugates (ADCs) and other next-generation biopharmaceuticals a pillar for medium- and long-term growth. The Japanese pharmaceutical company has initiated phase 2...
Sumitomo Rubber Limits Biopharmaceutical Deterioration With New Prefilled Syringe Stopper
Sumitomo Rubber Industries Ltd. (TYO:5110) has developed a rubber stopper that inhibits deterioration in biopharmaceuticals. Liquid biopharmaceuticals are delivered to end users in prefilled syringes that already contain the drug....
Asahi Kasei Launches Series of New Nonwovens
Asahi Kasei Corp. (TYO:3407) is forging ahead with the development of new nonwoven fabrics and their applications. The Japanese chemical manufacturer has created CMC-Bemliese by carboxymethylating a portion of the...
Fujifilm to Test Mass Production of Microneedle Arrays
Fujifilm Holdings Corp. (TYO:4901) is looking to accelerate the practical application of microneedle arrays – a drug delivery technology whereby a sheet adheres to the patient’s skin and administers drugs...
Teijin Works to Expand Orthopedic Implant Business
Teijin Ltd. (TYO:3401) is expanding its business operations both domestically and overseas for orthopedic medical devices, with this including artificial joints and other medical implants. To this end, the company...
Chemical and Material Manufacturers Eye Sustainable Growth in Health Care Sector
Chemical and material manufacturers are focusing their efforts in on the health care sector, seeing here little risk of fluctuation effects and as such expecting sustainable growth over the medium–long...
Daicel-Evonik Eyes New Ground for PEEK in Medical Sector
Daicel-Evonik Ltd. is speeding up efforts aimed at growth in Japan’s medical market. Many of the resins that the company deals in have already been used by German-based parent Evonik...
Eastman Targets Chinese Medical Market With Highly Chemical-Resistant Copolyester
Eastman Chemical Co. is gearing up to introduce its MXF221 copolyester to the Chinese market. Offering superior chemical resistance, use of the resin product for housing medical devices can enhance...
Taiyo Holdings Looks to Produce Drugs In-House
Taiyo Holdings Co. Ltd. (TYO:4626) has acquired long-listed drug business operations from Chugai Pharmaceutical Co. Ltd. (TYO:4519), and plans to acquire its own factory within the fiscal year to produce...
NISRI’s Chubu Technology Licensing Office Nears Real-World Applications for Spider Silk
The Nagoya Industrial Science Research Institute (NISRI) Chubu Technology Licensing Office (TLO) is bringing the practical use of spider silk closer to reality. The Chubu TLO is collaborating with Kurabo...
Interview: Pfizer Japan President Akihisa Harada Talks Business, New Drug Developments
Pfizer Japan Inc. last December saw a changing of the guard as Akihisa Harada, head of the Japanese branch’s Inflammation & Immunology unit, stepped in to take over from Ichiro...
Riken and Ricoh Prototype Artificial Bone With 3D Printing
A research group composed of members from the Institute of Physical and Chemical Research (Riken) and Ricoh Co. Ltd. (TYO:7752) has used 3D printing to develop a strong artificial bone...
Chuetsu Teams With Universities to Develop CNF for Medical, Resin Applications
Chuetsu Pulp & Paper Co. Ltd. (TYO:3877) is partnering with universities to augment research and development into cellulose nanofiber (CNF). As part of this, the company is working with the...
